Harthan AA, Nadiger M, McGarvey JS, Hanson K, Gharpure VP, Bjornstad EC, Chiotos K, Miller AS, Reikoff RA, Gajic O, Kumar V, Walkey AJ, Kashyap R, Tripathi S; Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals. Pharmacotherapy. 2022 Jul;42(7):529-539. doi: 10.1002/phar.2709. Epub 2022 Jun 27. PMID: 35661394; PMCID: PMC9347960.
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals
Lay Abstract and Manuscript Citation:
Find publication:
https://doi.org/10.1002/phar.2709
The lay abstract for this publication was generated using an AI model and reviewed by the lead author and the PEDSnet Engagement Core team.